Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
(2015) In Journal of Rheumatology 42(10). p.1906-1913- Abstract
- To study the efficacy and safety of anti-CD52 antibody (alemtuzumab) in the treatment of refractory and relapsing Behçet disease (BD).
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/7840910
- author
- Mohammad, Aladdin LU ; Smith, Rona M ; Chow, Yok W ; Chaudhry, Afzal N and Jayne, David R W
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Rheumatology
- volume
- 42
- issue
- 10
- pages
- 1906 - 1913
- publisher
- Journal of Rheumatology Publishing Company Limited
- external identifiers
-
- pmid:26276966
- wos:000362234900027
- scopus:84943224099
- pmid:26276966
- ISSN
- 0315-162X
- DOI
- 10.3899/jrheum.141344
- language
- English
- LU publication?
- yes
- id
- 73ecc71e-6c6f-4a26-bef4-f4060adf1666 (old id 7840910)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26276966?dopt=Abstract
- date added to LUP
- 2016-04-01 10:52:20
- date last changed
- 2022-04-28 02:13:26
@article{73ecc71e-6c6f-4a26-bef4-f4060adf1666,
abstract = {{To study the efficacy and safety of anti-CD52 antibody (alemtuzumab) in the treatment of refractory and relapsing Behçet disease (BD).}},
author = {{Mohammad, Aladdin and Smith, Rona M and Chow, Yok W and Chaudhry, Afzal N and Jayne, David R W}},
issn = {{0315-162X}},
language = {{eng}},
number = {{10}},
pages = {{1906--1913}},
publisher = {{Journal of Rheumatology Publishing Company Limited}},
series = {{Journal of Rheumatology}},
title = {{Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.}},
url = {{http://dx.doi.org/10.3899/jrheum.141344}},
doi = {{10.3899/jrheum.141344}},
volume = {{42}},
year = {{2015}},
}